STAT News

STAT+: Skylark Bio kicks off new gene therapy trial for deafness

Biotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.

By STAT News

1 min read
STAT+: Skylark Bio kicks off new gene therapy trial for deafness
STAT+: Skylark Bio kicks off new gene therapy trial for deafness

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights